Enable and Scale

Process development and optimization for biotech companies
OUR HAPPY CLIENTS

A one-stop shop from development to scale up for bioprocesses

Full-suite fermentation and downstream processing services at benchtop and pilot scale. 

Our Services

Fermentation optimization to improve yield
Fermentation optimization to improve yield

Strain testing in conditions replicating commercial manufacturing
Media and process optimization
GRAS oriented process development

Downstream process development to decrease product loss
Downstream process development to decrease product loss

Wide range of DSP unit operations optimization and scaling
Protein purification by multi-stage TFF
Spray drying development and scale up

Regulatory guidance
Regulatory guidance

Expertise in approval process with FDA
Process towards safety approval
Critical control point identification in process flow

Tech transfer to CMO
Tech transfer to CMO

Connections to large-scale producers, negotiation assistance, and tech transfer oversight for smooth transition to industrial-scale production

What can we do?

Plant Capabilities

A one-stop shop to bring your process to commercial scale.

Vessels ranging from 1.5L to 1,500L for stepwise scale up

Solid/liquid, liquid/liquid, slurries. Centrifuges, homogenizer, bead mill, chemical lysis. Strong expertise in industrial-scale cell lysis

Multi-stage TFFs, freeze dryers, spray dryers

HPLC, GC, UV, off-gas, mass spectrometer

Fermented Bubbles

What is holding back the bioeconomy? In conversation with Boston Bioprocess CEO Dr. Michael Tai

Ted Netland Categories: Announcements, News

While significant progress has been made in recent years to optimize microbial strains and drive efficiency in biomanufacturing, a disconnect between upstream and downstream work continues to hold back progress, claims Boston Bioprocess cofounder Dr. Michael Tai.

Founded in Boston in 2022 by Tai (formerly head of bioprocess at Motif FoodWorks) and Ted Netland, Boston Bioprocess moved to Champaign, Illinois, in 2023.

The firm, which offers fermentation and downstream processing services at benchtop and pilot-scale, supports a wide range of companies from startups to established players looking to optimize their processes or develop new products.

AgFunderNews (AFN) caught up with Tai (MT) at the SynBioBeta conference in San Jose to get his take on what is holding back the bioeconomy.

AFN: What problems were you trying to solve when you founded Boston Bioprocess?

MT: When we started Boston Bioprocess there was a significant relative weakness of offerings in the bench development and processing scale up area, compared with relatively strong capabilities in strain engineering and development in the front end.

You could be very familiar with the performance [of your strain/bioprocess] in a 500-liter bioreactor, but there is a significant gap to be able to accurately predict performance in a 500,000-liter bioreactor.

Likewise, it’s very hard to tell how [upstream] fermentation performance can be integrated with downstream performance. So if I have a 10g-per-liter protein and you ask me what is your final harvesting yield after multiple stages of, let’s say, TFF [tangential flow filtration], it’s still very hard to predict.

So one thing I believe is critical is the integration between upstream and downstream work. There is still a significant resource poured into optimizing fermentation but relatively speaking an insignificant amount of resource going into the downstream process to solve questions as small as anti-foam [a common additive in bioprocessing to prevent or reduce foam formation] interference.

So when an upstream engineer says, if I put five more milliliters of anti-foam in my process, I can increase my fermentation yield or titer by 10% before the downstream guys know about it, then you might have to sacrifice quite a bit of downstream yield.

So I do think that it’s the integration and the talent pipeline between the fermentation and downstream area that is, in my mind, probably the top priority if we want to build a better biotech industry.

Read the rest of the interview on AgFunderNews

iFAB Tech Hub Partners IBRL and Boston Bioprocess Scale Fermentation Tech

BACKED BY

Levervc VC
Gener8tor
FTW Ventures
Siddhi Capital

Stay in the Loop with Our Newsletter

Subscribe to our newsletter to get the latest and greatest.